Literature DB >> 10098514

Androgen modulation of luteinizing hormone secretion by female rat gonadotropes.

J L Turgeon1, D W Waring.   

Abstract

In the female, androgens can have negative and positive actions in the regulation of LH, but it is not clear how they may function during the reproductive cycle. Toward resolving these potentially conflicting roles for androgen, we used an in vitro model of preovulatory gonadotropes to examine the effect of proestrous levels of testosterone (1.7 nM) or dihydrotestosterone (DHT; 0.7 nM) on LH secretion in response to pulsatile GnRH (1 nM) or elevated extracellular K+ (54 mM). For female rat pituitary cells cultured in 17beta-estradiol (E2)-containing medium, androgen treatment for 16 h, but not for 4 h, inhibited the LH secretory response to a pulse of either GnRH or K+ by about 60% and suppressed the acute augmentation action of 20 nM progesterone on GnRH- or K+-induced LH secretion. In the absence of E2, DHT also decreased LH secretion induced by a pulse of GnRH. DHT's suppressive effect on progesterone could be partially overcome with increased progesterone (200 nM) or by removal of DHT during progesterone exposure. For pituitary cells transfected with a reporter plasmid containing three progesterone response elements, DHT only partially suppressed progesterone-stimulated transcriptional activity. The positive action of androgen (16 h) on LH secretion was elicited by multiple GnRH pulses with a latency of about 2 h after the first pulse; this facilitatory action of androgen did not require an E2 background and, therefore, is distinct from GnRH self priming. In summary, these data demonstrate both facilitatory and inhibitory actions of androgen on LH secretion function in female gonadotropes in vitro in the absence or presence of E2; these actions occur with a time course suggestive of a role for androgen in shaping the preovulatory LH surge. Androgen also markedly suppresses progesterone augmentation of stimulated LH secretion, which could be due in part to interference with the trans-activation function of the progesterone receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098514     DOI: 10.1210/endo.140.4.6642

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

Review 3.  Neuroendocrine consequences of androgen excess in female rodents.

Authors:  Eileen M Foecking; Melissa A McDevitt; Maricedes Acosta-Martínez; Teresa H Horton; Jon E Levine
Journal:  Horm Behav       Date:  2008-01-10       Impact factor: 3.587

Review 4.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

5.  Androgen receptor antagonism and an insulin sensitizer block the advancement of vaginal opening by high-fat diet in mice.

Authors:  Diana S Brill; Suzanne M Moenter
Journal:  Biol Reprod       Date:  2009-07-15       Impact factor: 4.285

6.  Luteinizing hormone pulsatility in patients with major ovarian hyperandrogenism.

Authors:  A Bachelot; K Laborde; J L Bresson; G Plu-Bureau; A Raynaud; X Bertagna; A Mogenet; M Mansour; V Lucas-Jouy; J-P Gayno; Y Reznik; J-M Kuhn; L Billaud; M-C Vacher-Lavenu; M Putterman; I Mowszowicz; P Touraine; F Kuttenn
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 7.  The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.

Authors:  Niki Katsiki; Eleni Georgiadou; Apostolos I Hatzitolios
Journal:  Drugs       Date:  2009-07-30       Impact factor: 9.546

Review 8.  Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.

Authors:  Katerina Harwood; Patricia Vuguin; Joan DiMartino-Nardi
Journal:  Horm Res       Date:  2007-04-05

9.  Changing pattern of gonadotropins in a patient with an adrenal-androgen secreting tumor.

Authors:  Jose Antonio Miguel Marcondes; Cristiano R G Barcellos; Michelle P Rocha; Hélio Bisi
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression.

Authors:  Mei-Jou Chen; Chia-Hung Chou; Shee-Uan Chen; Wei-Shiung Yang; Yu-Shih Yang; Hong-Nerng Ho
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.